Wed 07/20/2022 14:01 PM
Share this article:
Relevant Items:
Mallinckrodt Covenants Tear Sheet, Debt Documents Summaries
Mallinckrodt Debt Documents

Mallinckrodt plc develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. As previously reported, on Oct. 12, 2020, the company and certain of its subsidiaries entered into chapter 11 bankruptcy proceedings. On June 16, 2022, the company’s plan of reorganization became effective, and the company emerged from chapter 11 proceedings. Continue...
Share this article:
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2024 Reorg Research, Inc. All rights reserved.
Thank you for signing up
for Reorg on the Record!